News

NAD+ And Mental Health: Evidence, Limits And Clinical Review

Nicotinamide adenine dinucleotide, or NAD+, is a coenzyme involved in cellular energy metabolism, redox reactions and enzyme activity. These biological roles have generated interest in aging, neurological health and mental health. They do not, however, establish intravenous NAD+ as a treatment for depression, anxiety or another psychiatric condition.

Why Researchers Study NAD+ Biology

Brain cells require substantial energy and depend on healthy metabolic pathways. NAD+ also participates in processes related to DNA repair and cellular stress responses. Researchers are studying NAD+ metabolism and several precursor compounds, but findings from cells, animals, oral supplements and intravenous products should not be treated as equivalent.

What The Clinical Evidence Can Support

Human evidence for commercially administered intravenous NAD+ remains limited. A recent retrospective pilot compared IV NAD+ with intravenous nicotinamide riboside in a small real-world sample. It reported short-term tolerability findings, not proof that NAD+ treats depression or improves long-term mental health.

Small studies can help identify research questions, but they cannot establish broad effectiveness. Patients should be cautious with claims that an infusion will “reset” the brain, cure addiction, reverse depression or guarantee mental clarity.

Mental Health Assessment Comes First

Low mood, anxiety, poor concentration, sleep disturbance and fatigue can have many causes. A qualified clinician may assess symptom duration and severity, medication, substance use, sleep, thyroid function, anaemia, nutritional deficiencies and other medical factors. Urgent help is needed when there is risk of self-harm, psychosis, severe functional decline or another crisis.

Evidence-based mental healthcare may include psychotherapy, medication, lifestyle support and treatment of contributing medical conditions. NAD+ discussions should not delay, replace or interrupt appropriate psychiatric or psychological care.

Safety Questions For IV NAD+

• What exact ingredient, dose and infusion rate are proposed?
• Why is IV administration being considered rather than another approach?
• What evidence supports the stated goal?
• What symptoms can occur during infusion and how are they monitored?
• Could medication, pregnancy, kidney, liver or cardiovascular issues affect suitability?
• Who supervises the infusion and manages an adverse reaction?

Published preliminary data have described gastrointestinal symptoms, increased heart rate and chest pressure during some NAD+ infusions. Individual assessment and monitoring therefore matter, even when a service is marketed as wellness support.

A Responsible Role In Care Planning

NAD+ may be discussed as an adjunctive wellness or metabolic-support question after standard assessment, not as a stand-alone mental health solution. The consultation should define the goal, explain uncertainty, review contraindications and decide how any response would be measured.

The most credible answer is sometimes that evidence is not yet strong enough for the promised outcome. Patients benefit when emerging biology is presented with precision rather than converted into certainty.

MTHFR Gene Variants: Testing, Folate And Clinical Context

MTHFR is a gene involved in folate metabolism and one-carbon biochemical pathways. Common variants such as C677T and A1298C are widespread in the population. They are better described as gene variants than automatically labelled harmful “mutations.” A result should be interpreted alongside symptoms, medical history, diet, medication and relevant laboratory findings.

What The MTHFR Gene Does

The MTHFR enzyme helps the body process folate, which contributes to DNA synthesis, methylation and homocysteine metabolism. Variants can alter enzyme activity to different degrees, but genotype alone does not diagnose a disease or explain every symptom.

For example, homocysteine can also be influenced by vitamin B12 or B6 status, kidney function, thyroid health, smoking, medication, age and other factors. A useful review therefore looks beyond a single genetic result.

What Common Results Mean

People inherit one copy of the gene from each parent. A report may describe no tested variant, one copy of a variant or two copies. The clinical relevance differs by variant and personal context. The US Centers for Disease Control and Prevention notes that people with common MTHFR variants can process folic acid; a common variant is not, by itself, a reason to avoid folic acid.

When Testing May Be Discussed

A clinician may consider genetic or biochemical review when there is a specific clinical question, relevant family history, unexplained homocysteine elevation or a broader personalised nutrition assessment. Testing should have a defined purpose. Broad testing without a plan for interpretation can create anxiety without changing care.

Useful Information To Review Together

• The exact variant and whether one or two copies were reported.
• Folate, vitamin B12 and homocysteine results where clinically indicated.
• Diet, supplements and medication.
• Kidney, thyroid, pregnancy and cardiovascular context.
• Family history and the reason the test was ordered.

Avoid Over-Interpreting The Result

An MTHFR result should not be used alone to diagnose fatigue, mood disorders, autism, infertility, cardiovascular disease or other complex conditions. It also does not automatically determine which supplement a person should take. High-dose supplementation can be inappropriate for some patients and may obscure other deficiencies.

Patients who are pregnant, planning pregnancy, taking medicines that affect folate pathways or managing significant illness should discuss supplementation with their doctor. Genetic counsellors can help when a rare variant or family pattern requires more specialised interpretation.

From Data To A Sensible Plan

The practical goal is not to “treat a gene.” It is to identify whether the result adds useful context to a real clinical question. Where needed, combine genetic information with validated laboratory testing, symptoms and standard medical assessment before changing treatment or supplements.